MEDICA GROUP PLC

Director's Dealing • Apr 26, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1629X

Medica Group PLC

26 April 2019

Medica Group PLC

Director / PDMR Shareholding

Medica Group PLC (the "Company") announces that on 25 April 2019, the PDMRs listed below were granted options over ordinary shares of 0.2p each in the Company under the Company's Deferred Bonus Plan 2017 at a nil exercise price:

Name of PDMR	Number of shares subject to option
John Michael Graham	1,610
Anthony Leonard Lee	1,127
Dr Stephen Griffith Davies	1,610

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation, and set out more details of the transactions.

1.	Details of PDMR
(a)	Name	1.           John Michael Graham 2.           Anthony Leonard Lee 3.           Dr Stephen Griffith Davies
2.	Reason for notification
(b)	Position / status	1.           Chief Executive Officer 2.           Chief Financial Officer 3.           Medical Director and Responsible Officer
(c)	Initial notification / amendment	Initial notification in each case
3.	Details of the Issuer
(a)	Name	Medica Group PLC
(b)	LEI
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted
(a)	Description of the financial instrument	Ordinary shares of 0.2p each in the capital of the Company ("Shares")
(b)	Nature of the transaction	Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017
(c)	Price(s) and volume	Option Price nil in each case 1.           1,610 2.           1,127 3.           1,610
(d)	Aggregated information	N/A
(e)	Date of the transaction	25 April 2019
(f)	Place of the transaction	Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHCKPDNABKDPQB